| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.071 | 0.2 |